Source: Nature medicine [Nat Med] 2006 Jul; Vol. 12 (7), pp. 780-4.Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Print ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Periodical

Alzheimer disease: presenilin springs a leak.

Authors : Gandy S; Doeven MK; Poolman B

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*genetics ; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*pathology ; Amyloid beta-Peptides/Amyloid beta-Peptides/Amyloid beta-Peptides/*chemistry

Source: Nature medicine [Nat Med] 2006 Oct; Vol. 12 (10), pp. 1121-3.Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Print ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

Authors : Wyss-Coray T; Geriatric Research, Education and Clinical Center, Veterans Administration Palo Alto Health Care System, 3801 Miranda Avenue, Palo Alto, California 94304, USA.

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*physiopathology ; Inflammation/Inflammation/Inflammation/*physiopathology; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/complications

Source: Nature medicine [Nat Med] 2006 Sep; Vol. 12 (9), pp. 1005-15.Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Print ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease.

Authors : Tuszynski MH; Department of Neurosciences, University of California at San Diego, La Jolla 92093, USA. ; Thal L

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*therapy ; Cholinergic Fibers/Cholinergic Fibers/Cholinergic Fibers/*metabolism ; Genetic Therapy/Genetic Therapy/Genetic Therapy/*methods

Source: Nature medicine [Nat Med] 2005 May; Vol. 11 (5), pp. 551-5. Date of Electronic Publication: 2005 Apr 24.Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Print

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Report

Specificity of mechanisms for plaque removal after A beta immunotherapy for Alzheimer disease.

Authors : Akiyama H; McGeer PL

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/immunology ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/pathology ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/therapy

Source: Nature medicine [Nat Med] 2004 Feb; Vol. 10 (2), pp. 117-8; author reply 118-9.Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Print ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease.

Authors : Hock C; Division of Psychiatry Research, University of Zurich, Zurich, Switzerland.; Konietzko U

Subjects: Alzheimer Vaccines/Alzheimer Vaccines/Alzheimer Vaccines/*administration & dosage ; Amyloid beta-Peptides/Amyloid beta-Peptides/Amyloid beta-Peptides/*immunology ; Antibodies/Antibodies/Antibodies/*immunology

Source: Nature medicine [Nat Med] 2002 Nov; Vol. 8 (11), pp. 1270-5. Date of Electronic Publication: 2002 Oct 15.Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Print

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Periodical

Alzheimer protease hitches a ride.

Authors : Wolfe MS

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*enzymology ; Amyloid Precursor Protein Secretases/Amyloid Precursor Protein Secretases/Amyloid Precursor Protein Secretases/*metabolism; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/etiology

Source: Nature medicine [Nat Med] 2006 Dec; Vol. 12 (12), pp. 1352-4.Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Print ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Periodical

Alzheimer disease: BACE1 branches out.

Authors : Schubert C

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*genetics ; Amyloid Precursor Protein Secretases/Amyloid Precursor Protein Secretases/Amyloid Precursor Protein Secretases/*genetics ; Aspartic Acid Endopeptidases/Aspartic Acid Endopeptidases/Aspartic Acid Endopeptidases/*genetics

Source: Nature medicine [Nat Med] 2006 Oct; Vol. 12 (10), pp. 1123.Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Print ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model.

Authors : McLaurin J; Centre for Research in Neurodegenerative Diseases, 6 Queen's Park Crescent West, Toronto, Ontario M5S 3H2 Canada. ; Kierstead ME

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*genetics ; Amyloid beta-Protein Precursor/Amyloid beta-Protein Precursor/Amyloid beta-Protein Precursor/*chemistry ; Cyclohexanols/Cyclohexanols/Cyclohexanols/*antagonists & inhibitors

Source: Nature medicine [Nat Med] 2006 Jul; Vol. 12 (7), pp. 801-8. Date of Electronic Publication: 2006 Jun 11.Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Print

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid tests

Alzheimer disease: progress or profit?

Alzheimer disease: presenilin springs a leak.

Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease.

Specificity of mechanisms for plaque removal after A beta immunotherapy for Alzheimer disease.

Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease.

Alzheimer protease hitches a ride.

Alzheimer disease: BACE1 branches out.

Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model.

اتصل بنا

اتبع